Search
for

    Glossary Pegylated Interferon

    modified interferon with polyethylene glycol for prolonged therapeutic effect

    Pegylated Interferon, often abbreviated as PEG-IFN, is a modified form of interferon used to treat certain viral infections and cancers. The "pegylation" process involves attaching polyethylene glycol (PEG) molecules to the interferon, which helps to prolong its presence in the bloodstream, reduce the frequency of dosing, and minimize side effects. This modification enhances the therapeutic efficacy and patient compliance compared to standard interferon treatments.

    Research 10 of 362

    1. Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects Expert Opinion on Drug Safety · 2011 · 17 citations
    2. Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C The Korean Journal of Hepatology · 2011 · 17 citations
    3. Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin treatment for hepatitis C Journal of Clinical Virology · 2014 · 11 citations
    4. Exacerbation of alopecia areata during pegylated interferon alpha-2b and ribavirin therapy, possibly due to the collapse of hair follicle immune privilege European Journal of Dermatology · 2014 · 10 citations
    5. Irreversible alopecia universalis during treatment with pegylated interferon-ribavirin for chronic hepatitis C virus infection: Case report and published work review Hepatology Research · 2012 · 9 citations
    6. Alopecia universalis as a side effect of pegylated interferon α-ribavirin combination therapy for hepatitis C: a rare case report Journal of Chemotherapy · 2016 · 6 citations
    7. Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report Annals of Hepatology · 2014 · 3 citations
    8. Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy Hepatitis Monthly · 2015 · 2 citations
    9. Clinical Characteristics and Factors Associated with Hair Loss Severity in Chronic Hepatitis B Patients Receiving Pegylated Interferon-Alpha: A Retrospective Cohort Study Clinical Cosmetic and Investigational Dermatology · 2026
    10. Dermatological Manifestations of Pegylated Interferon alfa2a and Ribavirin Combination Therapy in Chronic HCV Patients Afro-Egyptian Journal of Infectious and Endemic Diseases · 2016
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →